巴西政府向布坦坦研究所投资14亿雷亚尔

Group 1 - The Brazilian government announced an investment of 1.4 billion reais in the Butantan Institute's dengue vaccine production center to improve healthcare supplies and infrastructure for immunobiologicals [1] - The dengue vaccine produced by the Butantan Institute is 100% domestically made in Brazil and is the only single-dose vaccine approved for individuals aged 12 to 59 [1] - President Lula emphasized the importance of multilateralism and expressed Brazil's willingness to collaborate with the United States and China, highlighting China's significant role in Brazil's vaccine sector [1]